Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Fluorescence Optical Imaging Technology

By Biotechdaily staff writers
Posted on 29 Aug 2003
A new fluorescence optical imaging technology allows in vivo imaging of molecular processes, which is expected to speed the research and development of new drugs.

The technology, called bonSAI, is designed to aid drug-target identification and early prioritization of candidate compounds, speeding research and decreasing time to market. More...
Molecular imaging allows noninvasive measurement of molecular and biologic processes, probing the molecular abnormalities that are the origin of disease rather than imaging the resulting conditions caused by the disease.

The technology was developed by Siemens Medical Solutions (Erlangen, Germany) in collaboration with Dr. Ralph Weissleder, M.D., Ph.D, director of the Center for Molecular Imaging Research at Massachusetts General Hospital (MGH, Boston, USA). The bonsai technology also has broad applications in basic academic research at an affordable price, states Siemens.

"The adaptation of fluorescent optical techniques to diagnostic imaging is now changing the way we visualize molecular processes in vivo and ultimately, in the clinic,” said Dr. Weissleder.





Related Links:
Siemens Medical

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
Clinical Informatics Platform
CLARION™
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.